The only reason I am stuck in this stock is due to a bad broker who consumed the koolaid by the gallon. If Epanova gets NCE status and 5 years exclusivity, the FDA clearly has an agenda against Amarin. Maybe the fact that Amarin is an Irish company ,with corporate guys located in New Jersey,with a 5% corporate tax rate,has made this a political ploy. There is no sound clinical reason to have turned down Anchor and then rescind the SPA.Triglycerides have no impact on human health? The Reduce-It trial could get the same treatment by the FDA as an invalid study to keep the target moving.